Ottobock, DE000BCK2223

Ottobock stock pre-market at EUR 49.58: medical technology group little changed

Published on 10/26/2026 at 08:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The medical-technology group serves people with limited mobility. At Lang & Schwarz the stock trades pre-market at EUR 49.58 on October 26, 2026, 0.57 percent above the Xetra close of October 23, 2026.

Business model and reporting date

  • Ottobock develops medical-technology products in prosthetics, neuro-orthotics and exoskeletons.
  • October 26, 2026, trading context is provided by Germany's DAX benchmark.
  • Ottobock stock trades pre-market at EUR 49.58 at 8:28 a.m. CET at Lang & Schwarz on October 26, 2026, 0.57 percent above the Xetra close of October 23, 2026.
Ottobock, DE000BCK2223, Illustration mit AI erstellt.

Ottobock develops medical-technology products in prosthetics, neuro-orthotics and exoskeletons for people with limited mobility, according to its investor-relations site. Ottobock stock trades pre-market at EUR 49.58 at 8:28 a.m. CET at Lang & Schwarz on October 26, 2026, 0.57 percent above the Xetra close of October 23, 2026 (EUR 49.30).

Ahead of the Xetra open

The indication is plus EUR 0.28 versus the Xetra close. The bid is EUR 49.30 and the ask is EUR 49.85, a spread of 1.11 percent, indicating thin pre-market trading. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Ottobock stock.

Business model and market context

The group earns revenue from medical-technology products and services in prosthetics, neuro-orthotics and exoskeletons, its investor-relations site says. For October 26, 2026, market context: Market report DAX.

More news and analysis on Ottobock stock

Disclaimer...
en | DE000BCK2223 | OTTOBOCK | boerse | 70412865 |